704-1025

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
704 (USA) · Dr. Tanaka
consented 2013-09-27

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-11 (study day 15.0); relationship: POSSIBLE

mild assessed

Mild ELECTROCARDIOGRAM ST SEGMENT DEPRESSION — outcome: RECOVERED/RESOLVED; onset 2013-10-11 (study day 15.0); relationship: POSSIBLE

moderate assessed

Moderate PALPITATIONS — outcome: RECOVERED/RESOLVED; onset 2013-09-28 (study day 2.0); relationship: REMOTE

moderate assessed

Moderate VERTIGO — outcome: RECOVERED/RESOLVED; onset 2013-09-28 (study day 2.0); relationship: POSSIBLE

mild assessed

Mild WOLFF-PARKINSON-WHITE SYNDROME — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-25 (study day 29.0); relationship: POSSIBLE

mild assessed

Mild WOLFF-PARKINSON-WHITE SYNDROME — outcome: RECOVERED/RESOLVED; onset 2013-10-25 (study day 29.0); relationship: POSSIBLE

Data queries

No data queries.